SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-009005
Filing Date
2021-02-12
Accepted
2021-02-12 16:30:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea135462-13ga2vivoop_genocea.htm SC 13G/A 50418
  Complete submission text file 0001213900-21-009005.txt   51963
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Subject) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87984 | Film No.: 21628145
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Filed by) CIK: 0001728970 (see all company filings)

IRS No.: 823132352 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A